Clinical Trials Directory

Trials / Active Not Recruiting

Active Not RecruitingNCT05414396

Eat, Move, Live Program for the Reduction of Cancer and Chronic Disease Risk in Underserved Communities

Reducing Cancer and Chronic Disease Risk in Underserved Communities: Eat, Move, Live Program

Status
Active Not Recruiting
Phase
N/A
Study type
Interventional
Enrollment
347 (actual)
Sponsor
City of Hope Medical Center · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

This clinical trial tests the Eat, Move, Live (EML) Program in reducing the risk of chronic diseases among underserved communities by improving healthy lifestyle practices, increasing physical activity and encouraging healthy eating behaviors. EML is a series of free culturally and linguistically appropriate nutrition and physical activity sessions. The interactive education segment of the EML Program is culturally responsive, and based on the community EML program, and topics will include: nutrition guidelines, reading food labels, recipe modification and healthy food preparation, eating healthy on a budget, chronic diseases information and prevention strategies. The EML program may help reduce the risk of cancer and chronic diseases by encouraging more physical activity and healthy eating behaviors.

Detailed description

PRIMARY OBJECTIVES: I. To evaluate program by assessing in combination with standard of care metformin: Changes in participants' knowledge, attitudes, and behavior. II. To evaluate program by assessing in combination with standard of care metformin: Changes in body measurements. III. To evaluate program by assessing in combination with standard of care metformin: Changes in biomarkers. OUTLINE: Participants attend EML program sessions weekly for 12 weeks including an educational session chronic disease risk reduction via nutrition and physical activity, a physical activity session, and a cooking/taste test demonstration.

Conditions

Interventions

TypeNameDescription
BEHAVIORALBehavioral InterventionAttend EML program sessions
OTHERQuestionnaire AdministrationAncillary studies

Timeline

Start date
2018-03-20
Primary completion
2026-10-12
Completion
2026-10-12
First posted
2022-06-10
Last updated
2025-12-05

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT05414396. Inclusion in this directory is not an endorsement.